These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35274098)

  • 21. Distribution of alternative untranslated regions within the mRNA of the CELF1 splicing factor affects its expression.
    Kajdasz A; Niewiadomska D; Sekrecki M; Sobczak K
    Sci Rep; 2022 Jan; 12(1):190. PubMed ID: 34996980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustainable recovery of MBNL activity in autoregulatory feedback loop in myotonic dystrophy.
    Rogalska Z; Sobczak K
    Mol Ther Nucleic Acids; 2022 Dec; 30():438-448. PubMed ID: 36420218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain-specific change in alternative splicing of Tau exon 6 in myotonic dystrophy type 1.
    Leroy O; Wang J; Maurage CA; Parent M; Cooper T; Buée L; Sergeant N; Andreadis A; Caillet-Boudin ML
    Biochim Biophys Acta; 2006 Apr; 1762(4):460-7. PubMed ID: 16487687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.
    Tang ZZ; Yarotskyy V; Wei L; Sobczak K; Nakamori M; Eichinger K; Moxley RT; Dirksen RT; Thornton CA
    Hum Mol Genet; 2012 Mar; 21(6):1312-24. PubMed ID: 22140091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.
    Jenquin JR; Coonrod LA; Silverglate QA; Pellitier NA; Hale MA; Xia G; Nakamori M; Berglund JA
    ACS Chem Biol; 2018 Sep; 13(9):2708-2718. PubMed ID: 30118588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1.
    Nutter CA; Kidd BM; Carter HA; Hamel JI; Mackie PM; Kumbkarni N; Davenport ML; Tuyn DM; Gopinath A; Creigh PD; Sznajder ŁJ; Wang ET; Ranum LPW; Khoshbouei H; Day JW; Sampson JB; Prokop S; Swanson MS
    Brain; 2023 Oct; 146(10):4217-4232. PubMed ID: 37143315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins.
    Wang ET; Cody NA; Jog S; Biancolella M; Wang TT; Treacy DJ; Luo S; Schroth GP; Housman DE; Reddy S; Lécuyer E; Burge CB
    Cell; 2012 Aug; 150(4):710-24. PubMed ID: 22901804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive transcriptome-wide analysis of spliceopathy correction of myotonic dystrophy using CRISPR-Cas9 in iPSCs-derived cardiomyocytes.
    Dastidar S; Majumdar D; Tipanee J; Singh K; Klein AF; Furling D; Chuah MK; VandenDriessche T
    Mol Ther; 2022 Jan; 30(1):75-91. PubMed ID: 34371182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
    Michel L; Huguet-Lachon A; Gourdon G
    PLoS One; 2015; 10(9):e0137620. PubMed ID: 26339785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy.
    Charizanis K; Lee KY; Batra R; Goodwin M; Zhang C; Yuan Y; Shiue L; Cline M; Scotti MM; Xia G; Kumar A; Ashizawa T; Clark HB; Kimura T; Takahashi MP; Fujimura H; Jinnai K; Yoshikawa H; Gomes-Pereira M; Gourdon G; Sakai N; Nishino S; Foster TC; Ares M; Darnell RB; Swanson MS
    Neuron; 2012 Aug; 75(3):437-50. PubMed ID: 22884328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1.
    Wojciechowska M; Taylor K; Sobczak K; Napierala M; Krzyzosiak WJ
    RNA Biol; 2014; 11(6):742-54. PubMed ID: 24824895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models.
    Cerro-Herreros E; Sabater-Arcis M; Fernandez-Costa JM; Moreno N; Perez-Alonso M; Llamusi B; Artero R
    Nat Commun; 2018 Jun; 9(1):2482. PubMed ID: 29946070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zebrafish deficient for Muscleblind-like 2 exhibit features of myotonic dystrophy.
    Machuca-Tzili LE; Buxton S; Thorpe A; Timson CM; Wigmore P; Luther PK; Brook JD
    Dis Model Mech; 2011 May; 4(3):381-92. PubMed ID: 21303839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamics and variability of transcriptomic dysregulation in congenital myotonic dystrophy during pediatric development.
    Hale MA; Bates K; Provenzano M; Johnson NE
    Hum Mol Genet; 2023 Apr; 32(9):1413-1428. PubMed ID: 36222125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy.
    Orengo JP; Chambon P; Metzger D; Mosier DR; Snipes GJ; Cooper TA
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2646-51. PubMed ID: 18272483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmental insights into the pathology of and therapeutic strategies for DM1: Back to the basics.
    Chau A; Kalsotra A
    Dev Dyn; 2015 Mar; 244(3):377-90. PubMed ID: 25504326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes.
    Kim EY; Barefield DY; Vo AH; Gacita AM; Schuster EJ; Wyatt EJ; Davis JL; Dong B; Sun C; Page P; Dellefave-Castillo L; Demonbreun A; Zhang HF; McNally EM
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30730308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
    Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
    Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compound loss of muscleblind-like function in myotonic dystrophy.
    Lee KY; Li M; Manchanda M; Batra R; Charizanis K; Mohan A; Warren SA; Chamberlain CM; Finn D; Hong H; Ashraf H; Kasahara H; Ranum LP; Swanson MS
    EMBO Mol Med; 2013 Dec; 5(12):1887-900. PubMed ID: 24293317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.